The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...
Since 2012, they used both NIH suspicion scores and the Prostate Imaging – Reporting and Data System (PI-RADS) scoring system. During 2007 to 2010, clinically significant PCa was detected at similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results